Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
1 Jun, 26
ECO 2026
Key sessions presented presented at 33rd European Congress on Obesity held at Istanbul, Türkey.
1 Jun, 26ECO 2026
Key sessions presented presented at 33rd European Congress on Obesity held at Istanbul, Türkey.
9 Jun, 26Diabetes Obes Metab.
- Data for 442,666 Korean adults revealed differential link between mortality risk & metabolic–obesity phenotypes
- Compared with metabolically healthy lean, metabolically unhealthy lean had higher risk for all cause mortality (HR 1.23), while metabolically healthy obesity had lower risk (HR 0.85)
- Higher physical activity consistently reduced all cause & CVD mortality across all phenotypes in a dose response manner.
9 Jun, 26Br. J. Dermatol.
- Among AD patients, global prevalence was 20.1% for asthma, 45.1% for rhinitis, 41.4% for allergic rhinitis, 30.7% for rhinoconjunctivitis &10.4% for coexistence.
- Compared with controls, AD was associated with higher odds of asthma (OR 2.73), rhinitis (OR 2.98) & rhinoconjunctivitis (OR 4.21).
- Prevalence varied widely (asthma 2.5–59.4%; rhinitis 7.8–82.7%) and was higher in physician-diagnosed AD cases.
5 Jun, 26Diabetes Ther.
- The study enrolled 186 patients with diabetes related Charcot neuro osteoarthropathy (195 CN feet, median follow up: 8.2 yrs)
- Male sex (p=0.026) & prior amputation (p=0.003) raised amputation risk
- Mortality rates were 2.7% at 1 yr, 18.9% at 5 yrs, & 40% at 10 yrs. Prior amputation (p=0.005) & worsening CKD stage (p=0.027) predicted higher mortality, underscoring need for early, aggressive risk factor management.
3 Jun, 26BMC Infect. Dis.
- Visceral Leishmaniasis can mimic leukemia; consider in endemic regions to avoid misdiagnosis
- PCR is most sensitive; microscopy may miss cases, serology moderately reliable
- Common signs: fever, splenomegaly, anemia; frequently overlaps with Acute lymphoblastic leukemia
- Early diagnosis enables effective treatment; prevents unnecessary invasive tests.
9 Jun, 26
Featured
Key Trials
27 May, 26
27 May, 26
Key Trials
27 May, 26
27 May, 26
27 May, 26
